Jennifer Lynn Irani, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Digestive System Surgical Procedures | 5 | 2022 | 584 | 1.360 |
Why?
|
Rectal Neoplasms | 7 | 2024 | 1183 | 0.690 |
Why?
|
Anus Neoplasms | 5 | 2024 | 336 | 0.670 |
Why?
|
Judgment | 1 | 2018 | 270 | 0.510 |
Why?
|
Enterostomy | 1 | 2013 | 14 | 0.430 |
Why?
|
Surgical Stomas | 1 | 2013 | 45 | 0.410 |
Why?
|
Perineum | 4 | 2024 | 212 | 0.400 |
Why?
|
General Surgery | 5 | 2015 | 1720 | 0.380 |
Why?
|
Urethral Stricture | 1 | 2011 | 50 | 0.380 |
Why?
|
Appendectomy | 3 | 2019 | 444 | 0.370 |
Why?
|
Competency-Based Education | 2 | 2010 | 226 | 0.370 |
Why?
|
Survival Rate | 24 | 2021 | 12823 | 0.370 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2019 | 1536 | 0.360 |
Why?
|
Androgen Antagonists | 1 | 2019 | 1412 | 0.350 |
Why?
|
Dilatation | 1 | 2011 | 311 | 0.340 |
Why?
|
Renal Insufficiency | 2 | 2012 | 812 | 0.330 |
Why?
|
Urethra | 1 | 2011 | 406 | 0.320 |
Why?
|
Neoplasm Staging | 20 | 2021 | 11217 | 0.320 |
Why?
|
Rectum | 3 | 2022 | 898 | 0.320 |
Why?
|
Neoplasm Recurrence, Local | 10 | 2020 | 9410 | 0.310 |
Why?
|
Testosterone | 1 | 2019 | 2490 | 0.300 |
Why?
|
Colorectal Surgery | 2 | 2020 | 125 | 0.290 |
Why?
|
Appendiceal Neoplasms | 2 | 2019 | 155 | 0.280 |
Why?
|
Urinary Bladder Neoplasms | 5 | 2018 | 2186 | 0.280 |
Why?
|
Hyperthermia, Induced | 2 | 2021 | 414 | 0.270 |
Why?
|
Treatment Refusal | 2 | 2020 | 433 | 0.270 |
Why?
|
Nephrectomy | 2 | 2011 | 928 | 0.270 |
Why?
|
Internship and Residency | 5 | 2018 | 5947 | 0.270 |
Why?
|
Operating Rooms | 2 | 2010 | 790 | 0.270 |
Why?
|
Pancreatic Diseases | 1 | 2008 | 354 | 0.260 |
Why?
|
Self Care | 1 | 2011 | 800 | 0.260 |
Why?
|
Colorectal Neoplasms | 6 | 2021 | 6966 | 0.240 |
Why?
|
Colon | 2 | 2022 | 1797 | 0.230 |
Why?
|
Clinical Clerkship | 1 | 2010 | 569 | 0.230 |
Why?
|
Peritoneal Neoplasms | 2 | 2021 | 706 | 0.220 |
Why?
|
Pancreatectomy | 1 | 2008 | 825 | 0.220 |
Why?
|
Colonic Neoplasms | 3 | 2020 | 2535 | 0.210 |
Why?
|
Appendicitis | 2 | 2019 | 679 | 0.200 |
Why?
|
Neuroendocrine Tumors | 2 | 2019 | 659 | 0.200 |
Why?
|
Graft Survival | 1 | 2012 | 3896 | 0.190 |
Why?
|
Personnel Staffing and Scheduling | 1 | 2005 | 497 | 0.190 |
Why?
|
Surgical Flaps | 3 | 2024 | 1680 | 0.190 |
Why?
|
Medical Staff, Hospital | 1 | 2005 | 602 | 0.180 |
Why?
|
Kidney Neoplasms | 5 | 2017 | 4282 | 0.180 |
Why?
|
Retrospective Studies | 28 | 2024 | 81659 | 0.180 |
Why?
|
Databases, Factual | 6 | 2021 | 8068 | 0.180 |
Why?
|
Follow-Up Studies | 17 | 2019 | 39317 | 0.180 |
Why?
|
Carcinoma, Transitional Cell | 3 | 2018 | 790 | 0.180 |
Why?
|
Carcinoma, Squamous Cell | 3 | 2021 | 4049 | 0.170 |
Why?
|
France | 2 | 2012 | 496 | 0.170 |
Why?
|
BCG Vaccine | 3 | 2018 | 381 | 0.170 |
Why?
|
Duodenal Neoplasms | 1 | 2020 | 114 | 0.170 |
Why?
|
Prostatitis | 1 | 1999 | 102 | 0.160 |
Why?
|
Lymph Nodes | 3 | 2020 | 3468 | 0.160 |
Why?
|
Sigmoidoscopy | 1 | 2019 | 150 | 0.160 |
Why?
|
Omentum | 1 | 2019 | 168 | 0.150 |
Why?
|
Carcinoma, Large Cell | 1 | 2019 | 114 | 0.150 |
Why?
|
Goals | 1 | 2023 | 717 | 0.150 |
Why?
|
Middle Aged | 40 | 2020 | 223233 | 0.150 |
Why?
|
Carcinoid Tumor | 1 | 2019 | 225 | 0.150 |
Why?
|
Intestinal Neoplasms | 1 | 2020 | 314 | 0.140 |
Why?
|
Abdominal Abscess | 1 | 2018 | 152 | 0.140 |
Why?
|
Kidney Transplantation | 1 | 2012 | 4268 | 0.140 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 6 | 2021 | 11872 | 0.140 |
Why?
|
Adenocarcinoma | 7 | 2020 | 6360 | 0.140 |
Why?
|
Emotional Intelligence | 1 | 2018 | 135 | 0.140 |
Why?
|
Hematologic Neoplasms | 1 | 2008 | 1907 | 0.140 |
Why?
|
Carcinoma, Small Cell | 1 | 2019 | 419 | 0.130 |
Why?
|
Humans | 59 | 2024 | 767040 | 0.130 |
Why?
|
Leiomyosarcoma | 1 | 2020 | 426 | 0.130 |
Why?
|
Education, Medical, Graduate | 2 | 2005 | 2420 | 0.130 |
Why?
|
Chemotherapy, Adjuvant | 3 | 2019 | 3552 | 0.130 |
Why?
|
Graft vs Host Disease | 1 | 2008 | 3049 | 0.130 |
Why?
|
Microwaves | 1 | 2017 | 184 | 0.130 |
Why?
|
Male | 42 | 2021 | 364203 | 0.130 |
Why?
|
Aged | 27 | 2020 | 171319 | 0.120 |
Why?
|
Adenocarcinoma, Mucinous | 1 | 2019 | 523 | 0.120 |
Why?
|
Mesothelioma | 1 | 2021 | 774 | 0.120 |
Why?
|
Clinical Competence | 2 | 2010 | 4859 | 0.120 |
Why?
|
Cystectomy | 2 | 2018 | 603 | 0.120 |
Why?
|
Aged, 80 and over | 14 | 2020 | 59548 | 0.120 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 2019 | 343 | 0.120 |
Why?
|
Endoscopy | 2 | 2022 | 1854 | 0.120 |
Why?
|
Neoplasm Invasiveness | 4 | 2020 | 3611 | 0.120 |
Why?
|
Personality | 1 | 2018 | 559 | 0.120 |
Why?
|
Prognosis | 12 | 2020 | 29963 | 0.110 |
Why?
|
Disease-Free Survival | 4 | 2019 | 6844 | 0.110 |
Why?
|
Healthcare Disparities | 2 | 2019 | 3414 | 0.110 |
Why?
|
Prolapse | 1 | 2013 | 63 | 0.110 |
Why?
|
United States | 11 | 2022 | 72971 | 0.110 |
Why?
|
Abdomen | 1 | 2019 | 1138 | 0.100 |
Why?
|
Antidiarrheals | 1 | 2013 | 46 | 0.100 |
Why?
|
Combined Modality Therapy | 8 | 2021 | 8535 | 0.100 |
Why?
|
Hernia | 1 | 2013 | 67 | 0.100 |
Why?
|
Ureteral Diseases | 1 | 2012 | 63 | 0.100 |
Why?
|
Surgical Wound Infection | 2 | 2019 | 1547 | 0.100 |
Why?
|
Dermatitis, Contact | 1 | 2013 | 134 | 0.100 |
Why?
|
Colostomy | 1 | 2013 | 107 | 0.100 |
Why?
|
Professional Competence | 1 | 2015 | 430 | 0.100 |
Why?
|
Female | 38 | 2021 | 396660 | 0.100 |
Why?
|
Ileostomy | 1 | 2013 | 122 | 0.100 |
Why?
|
Prostatectomy | 2 | 1999 | 1786 | 0.100 |
Why?
|
Treatment Outcome | 12 | 2019 | 65295 | 0.100 |
Why?
|
Quality of Life | 2 | 2011 | 13485 | 0.100 |
Why?
|
Postoperative Complications | 6 | 2024 | 15824 | 0.100 |
Why?
|
Pyoderma Gangrenosum | 1 | 2013 | 84 | 0.100 |
Why?
|
Career Choice | 1 | 2018 | 769 | 0.100 |
Why?
|
Urolithiasis | 1 | 2012 | 123 | 0.090 |
Why?
|
Lymphoma | 1 | 2020 | 1896 | 0.090 |
Why?
|
Ureteral Obstruction | 1 | 2012 | 293 | 0.090 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2008 | 5716 | 0.090 |
Why?
|
Surgical Mesh | 1 | 2013 | 315 | 0.080 |
Why?
|
Adenocarcinoma, Clear Cell | 1 | 2011 | 218 | 0.080 |
Why?
|
Radiography, Interventional | 1 | 2017 | 1129 | 0.080 |
Why?
|
Diagnostic Self Evaluation | 1 | 2011 | 228 | 0.080 |
Why?
|
Carcinoma, Renal Cell | 2 | 2017 | 3186 | 0.080 |
Why?
|
Urinary Incontinence, Stress | 1 | 1991 | 180 | 0.080 |
Why?
|
Adult | 21 | 2019 | 223317 | 0.080 |
Why?
|
Catheters, Indwelling | 1 | 2011 | 436 | 0.080 |
Why?
|
Patient Protection and Affordable Care Act | 1 | 2019 | 1188 | 0.080 |
Why?
|
Hospitals, Community | 2 | 2021 | 363 | 0.080 |
Why?
|
Vesico-Ureteral Reflux | 1 | 2012 | 433 | 0.080 |
Why?
|
Incidence | 5 | 2021 | 21526 | 0.080 |
Why?
|
Necrosis | 1 | 2012 | 1614 | 0.080 |
Why?
|
Sodium-Glucose Transporter 1 | 1 | 2008 | 108 | 0.070 |
Why?
|
Urinary Incontinence | 1 | 2012 | 490 | 0.070 |
Why?
|
Testicular Neoplasms | 1 | 1994 | 806 | 0.070 |
Why?
|
Health Status Disparities | 1 | 2019 | 1882 | 0.070 |
Why?
|
Survival Analysis | 3 | 2020 | 10092 | 0.070 |
Why?
|
Crohn Disease | 1 | 2020 | 2295 | 0.070 |
Why?
|
Acute Kidney Injury | 1 | 2019 | 1946 | 0.070 |
Why?
|
Intestinal Absorption | 1 | 2008 | 400 | 0.070 |
Why?
|
Laparoscopy | 1 | 2018 | 2037 | 0.070 |
Why?
|
Creatinine | 1 | 2012 | 1916 | 0.070 |
Why?
|
Mucous Membrane | 1 | 2010 | 659 | 0.070 |
Why?
|
Suture Techniques | 1 | 1991 | 775 | 0.060 |
Why?
|
Liver Neoplasms | 1 | 2021 | 4357 | 0.060 |
Why?
|
Medicaid | 1 | 2019 | 2836 | 0.060 |
Why?
|
Vagina | 1 | 1991 | 849 | 0.060 |
Why?
|
Secondary Prevention | 1 | 2011 | 1472 | 0.060 |
Why?
|
Mitomycin | 2 | 2019 | 261 | 0.060 |
Why?
|
Sepsis | 1 | 2018 | 2605 | 0.060 |
Why?
|
Faculty, Medical | 2 | 2010 | 1227 | 0.060 |
Why?
|
Early Detection of Cancer | 1 | 2019 | 3236 | 0.060 |
Why?
|
Attitude of Health Personnel | 2 | 2010 | 3928 | 0.060 |
Why?
|
Intestine, Small | 2 | 2020 | 1217 | 0.060 |
Why?
|
Risk Factors | 5 | 2019 | 74886 | 0.050 |
Why?
|
Catheter Ablation | 1 | 2017 | 2787 | 0.050 |
Why?
|
Ileum | 2 | 2020 | 558 | 0.050 |
Why?
|
Antibiotics, Antineoplastic | 2 | 2019 | 678 | 0.050 |
Why?
|
Job Satisfaction | 1 | 2005 | 548 | 0.050 |
Why?
|
Multivariate Analysis | 3 | 2019 | 12069 | 0.050 |
Why?
|
Time Factors | 3 | 2012 | 40154 | 0.050 |
Why?
|
Health Services Accessibility | 1 | 2019 | 5519 | 0.050 |
Why?
|
Cell Compartmentation | 1 | 2021 | 383 | 0.040 |
Why?
|
Proportional Hazards Models | 3 | 2020 | 12536 | 0.040 |
Why?
|
Leukocytosis | 1 | 2001 | 248 | 0.040 |
Why?
|
Melanoma | 1 | 2018 | 5702 | 0.040 |
Why?
|
Urine | 1 | 2001 | 362 | 0.040 |
Why?
|
Age Factors | 4 | 2020 | 18401 | 0.040 |
Why?
|
Pelvis | 1 | 2024 | 736 | 0.040 |
Why?
|
Prostatic Neoplasms | 2 | 1999 | 11097 | 0.040 |
Why?
|
DNA Mismatch Repair | 1 | 2021 | 431 | 0.040 |
Why?
|
Acute Disease | 1 | 2008 | 7236 | 0.040 |
Why?
|
Surgical Wound Dehiscence | 1 | 2019 | 215 | 0.040 |
Why?
|
Biology | 1 | 2020 | 292 | 0.040 |
Why?
|
Behavioral Risk Factor Surveillance System | 1 | 2019 | 212 | 0.040 |
Why?
|
Hepatectomy | 1 | 2021 | 589 | 0.040 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2001 | 594 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 3 | 2017 | 20741 | 0.030 |
Why?
|
Chemokines | 1 | 2021 | 963 | 0.030 |
Why?
|
Students, Medical | 1 | 2010 | 1965 | 0.030 |
Why?
|
Drug Therapy | 1 | 2020 | 504 | 0.030 |
Why?
|
Severity of Illness Index | 2 | 2008 | 15925 | 0.030 |
Why?
|
Circadian Rhythm | 1 | 2008 | 2591 | 0.030 |
Why?
|
Myeloid Cells | 1 | 2021 | 837 | 0.030 |
Why?
|
Administration, Intravesical | 2 | 2010 | 88 | 0.030 |
Why?
|
Glucose | 1 | 2008 | 4341 | 0.030 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2021 | 845 | 0.030 |
Why?
|
Patient Preference | 1 | 2023 | 947 | 0.030 |
Why?
|
Stromal Cells | 1 | 2021 | 1335 | 0.030 |
Why?
|
Immunity | 1 | 2021 | 1002 | 0.030 |
Why?
|
Carcinoma in Situ | 1 | 2001 | 784 | 0.030 |
Why?
|
Length of Stay | 2 | 2019 | 6489 | 0.030 |
Why?
|
Thigh | 1 | 2016 | 236 | 0.030 |
Why?
|
Guideline Adherence | 1 | 2005 | 2232 | 0.030 |
Why?
|
Lithotripsy | 1 | 1995 | 137 | 0.030 |
Why?
|
Cross-Sectional Studies | 3 | 2021 | 26325 | 0.030 |
Why?
|
Ureteral Calculi | 1 | 1995 | 111 | 0.030 |
Why?
|
Prospective Studies | 5 | 2019 | 54886 | 0.030 |
Why?
|
Carcinoembryonic Antigen | 1 | 2015 | 338 | 0.030 |
Why?
|
Antineoplastic Agents | 3 | 2010 | 13650 | 0.030 |
Why?
|
Canada | 1 | 2019 | 2127 | 0.030 |
Why?
|
Age Distribution | 1 | 2019 | 2870 | 0.030 |
Why?
|
Testicular Hydrocele | 1 | 1993 | 27 | 0.030 |
Why?
|
Bleomycin | 1 | 1994 | 492 | 0.030 |
Why?
|
Seminoma | 1 | 1994 | 136 | 0.030 |
Why?
|
Sclerosing Solutions | 1 | 1993 | 79 | 0.030 |
Why?
|
Vinblastine | 1 | 1994 | 482 | 0.030 |
Why?
|
Cohort Studies | 3 | 2021 | 41718 | 0.030 |
Why?
|
Etoposide | 1 | 1994 | 639 | 0.030 |
Why?
|
Adolescent | 4 | 2011 | 89046 | 0.030 |
Why?
|
Salvage Therapy | 1 | 2019 | 1271 | 0.030 |
Why?
|
Propensity Score | 1 | 2020 | 1971 | 0.020 |
Why?
|
Orchiectomy | 1 | 1994 | 466 | 0.020 |
Why?
|
Accreditation | 1 | 2015 | 477 | 0.020 |
Why?
|
Monocytes | 1 | 2021 | 2598 | 0.020 |
Why?
|
Minocycline | 1 | 1993 | 170 | 0.020 |
Why?
|
Minority Groups | 1 | 2019 | 1214 | 0.020 |
Why?
|
Endosonography | 1 | 2015 | 626 | 0.020 |
Why?
|
Kidney Calculi | 1 | 1995 | 458 | 0.020 |
Why?
|
Algorithms | 1 | 2011 | 14098 | 0.020 |
Why?
|
Methods | 1 | 1991 | 1065 | 0.020 |
Why?
|
Colectomy | 1 | 2015 | 696 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2021 | 2902 | 0.020 |
Why?
|
Phlorhizin | 1 | 2008 | 37 | 0.020 |
Why?
|
Neutrophils | 1 | 2021 | 3779 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2021 | 3582 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2019 | 5311 | 0.020 |
Why?
|
Remission Induction | 1 | 1994 | 2408 | 0.020 |
Why?
|
Lymph Node Excision | 1 | 1994 | 1267 | 0.020 |
Why?
|
Cisplatin | 1 | 1994 | 1656 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2018 | 6513 | 0.020 |
Why?
|
Insurance, Health | 1 | 2020 | 2519 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2021 | 7611 | 0.020 |
Why?
|
Colonoscopy | 1 | 2015 | 1409 | 0.020 |
Why?
|
Poverty | 1 | 2019 | 2719 | 0.020 |
Why?
|
Jejunum | 1 | 2008 | 474 | 0.020 |
Why?
|
Sex Factors | 1 | 2020 | 10622 | 0.020 |
Why?
|
Patient Readmission | 1 | 2019 | 3283 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2021 | 8628 | 0.020 |
Why?
|
Patient Compliance | 1 | 2015 | 2697 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2021 | 17097 | 0.010 |
Why?
|
Logistic Models | 1 | 2019 | 13284 | 0.010 |
Why?
|
Contrast Media | 1 | 2017 | 5329 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2021 | 10254 | 0.010 |
Why?
|
Postoperative Care | 1 | 2010 | 1480 | 0.010 |
Why?
|
Calcinosis | 1 | 1991 | 1481 | 0.010 |
Why?
|
Gravity Sensing | 1 | 2001 | 5 | 0.010 |
Why?
|
Inflammation | 1 | 2021 | 10869 | 0.010 |
Why?
|
Work Schedule Tolerance | 1 | 2005 | 553 | 0.010 |
Why?
|
Kidney Diseases | 1 | 1991 | 2099 | 0.010 |
Why?
|
Urography | 2 | 1991 | 316 | 0.010 |
Why?
|
Workload | 1 | 2005 | 849 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2005 | 3431 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2008 | 8108 | 0.010 |
Why?
|
Leukocyte Count | 1 | 2001 | 1606 | 0.010 |
Why?
|
Risk Assessment | 1 | 2018 | 24299 | 0.010 |
Why?
|
Forecasting | 1 | 2005 | 2936 | 0.010 |
Why?
|
Data Collection | 1 | 2005 | 3321 | 0.010 |
Why?
|
Angiography | 2 | 1991 | 1597 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2008 | 12793 | 0.010 |
Why?
|
ROC Curve | 1 | 2001 | 3618 | 0.010 |
Why?
|
Administration, Intravaginal | 1 | 1993 | 149 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2010 | 7435 | 0.010 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2007 | 4054 | 0.010 |
Why?
|
Injections, Intralesional | 1 | 1993 | 280 | 0.010 |
Why?
|
Physician-Patient Relations | 1 | 2005 | 3266 | 0.010 |
Why?
|
Rats | 1 | 2008 | 23713 | 0.010 |
Why?
|
Cyproterone Acetate | 1 | 1991 | 5 | 0.010 |
Why?
|
Ultrasonography | 2 | 1995 | 6000 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2008 | 11923 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 1997 | 21178 | 0.010 |
Why?
|
Biopsy | 2 | 1991 | 6777 | 0.010 |
Why?
|
Mastectomy | 1 | 1997 | 1861 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2015 | 36582 | 0.000 |
Why?
|
Cell Nucleus | 1 | 1994 | 2875 | 0.000 |
Why?
|
Disease Progression | 1 | 2001 | 13646 | 0.000 |
Why?
|
Prostate-Specific Antigen | 1 | 1991 | 2463 | 0.000 |
Why?
|
Recurrence | 1 | 1993 | 8504 | 0.000 |
Why?
|
Animals | 1 | 2008 | 168965 | 0.000 |
Why?
|
Child | 1 | 1995 | 80771 | 0.000 |
Why?
|